Saturday, February 4, 2012
"Concise industry news from the US pharmaceutical industry..."
1 of 18
Previous |
Next
Executive Interviews
Balancing act: aligning competing strategic objectives in turbulent times
IMS offers insight to new commercial model and launch excellence initiatives.
No Comments
REACH out for better
As the industry raises the bar once again to protect human health and the environment against chemical substances, Ali S. Faqi discusses the implications of the REACH initiative for manufacturers of chemical substances.
No Comments
Below the surface
As companies continue to magnify their efforts in the realms of manufacturing, Jeffrey L. Mooney highlights the importance in utilizing sufficient surface technologies.
No Comments
A national asset
Dave Shanahan shows us how a country as relatively small as Ireland continues to push the industry in every possible context – and with the biggest possible heart.
No Comments
Don’t be fazed by phases
Mike Butler explains how Xceleron is helping its clients to answer critical clinical development questions.
No Comments
1 of 18
Previous |
Next
Source: www.ngpharma.com© 2012 GDS Publishing Ltd. All rights reserved.